Xiaowen Ding

No. 150 Dongfang Street, Xiasha Street, Qiantang District
Hangzhou, 310000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells.

PARP14-mediated glycolysis enhances Tamoxifen resistance in estrogen receptor + breast cancer cells.

Journal: Discover oncology

Published: July 19, 2024

LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.

LncRNA TDRKH-AS1 promotes breast cancer progression via the miR-134-5p/CREB1 axis.

Journal: Journal of translational medicine

Published: August 17, 2023

Long non-coding RNAs in breast cancer stem cells.

Long non-coding RNAs in breast cancer stem cells.

Journal: Medical oncology (Northwood, London, England)

Published: April 04, 2023

Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Neoadjuvant Pyrotinib plus Trastuzumab, Docetaxel, and Carboplatin in Early or Locally Advanced Human Epidermal Receptor 2-Positive Breast Cancer in China: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.

Journal: Oncology research and treatment

Published: March 26, 2023

The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients.

The Value of Neoadjuvant Anthracycline-Based Regimens for HER2-Positive Breast Cancer: A Systematic Review and Meta-analysis Including 1366 Patients.

Journal: Clinical Medicine Insights. Oncology

Published: January 11, 2023

Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China: A Randomized Clinical Trial.

Effects of Gonadotropin-Releasing Hormone Analogs on Ovarian Function Against Chemotherapy-Induced Gonadotoxic Effects in Premenopausal Women With Breast Cancer in China: A Randomized Clinical Trial.

Journal: JAMA oncology

Published: December 30, 2021

Associations Between Serum Reproductive Hormone Concentrations and Hormonal Receptor Status Among Postmenopausal Chinese Women With Breast Cancer: An Observational Study.

Associations Between Serum Reproductive Hormone Concentrations and Hormonal Receptor Status Among Postmenopausal Chinese Women With Breast Cancer: An Observational Study.

Journal: Frontiers in oncology

Published: November 22, 2021

Study of lncRNA TPA in Promoting Invasion and Metastasis of Breast Cancer Mediated by TGF-β Signaling Pathway.

Study of lncRNA TPA in Promoting Invasion and Metastasis of Breast Cancer Mediated by TGF-β Signaling Pathway.

Journal: Frontiers in cell and developmental biology

Published: March 31, 2021

The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience.

The treatment option of progressive disease in breast cancer during neoadjuvant chemotherapy: a single-center experience.

Journal: Cancer biology & therapy

Published: May 19, 2020

Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.

Identification of a 6-gene signature for the survival prediction of breast cancer patients based on integrated multi-omics data analysis.

Journal: PloS one

Published: March 18, 2020

Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients.

Does dose-dense neoadjuvant chemotherapy have clinically significant prognostic value in breast cancer?: A meta-analysis of 3,724 patients.

Journal: PloS one

Published: February 24, 2020

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.

Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer.

Journal: PloS one

Published: January 27, 2020

Showing 1-12 of 20

Last Updated: 09/26/2026